The atrial appendage occluder market size is projected to be valued at US$ 983.5 million in 2023 and is expected to rise to US$ 8193.0 million by 2033. The sales of atrial appendage occluders are projected to expand at a significant CAGR of 23.6% during the forecast period.
The atrial appendage, better described as the left atrial appendage (LAA) is an ear-shaped pouch present in the top left chamber of the human heart (Left Atrium). The functional significance of this structure is unknown. In patients living with arrhythmic cardiovascular conditions such as atrial fibrillation, blood accumulates in the left atrial appendage and can cause clotting of blood.
The blood clots can cause fatal strokes when pumped into the blood vessels. Along with oral anticoagulants, occlusion of LAA by an occluder is an alternative approach to protect cardiovascular patients from strokes and other complications. An atrial appendage occluder is thus a kind of plug that permanently closes the appendage.
According to a study published in the journal, Clinical Medical Insights, Cardiology, atrial fibrillation affects around 2 percent of the global population and the prevalence of the disease is expected to increase five times over the next four decades, especially in the United States, owing to the expanding elderly population base.
| Attributes | Details |
|---|---|
| Atrial Appendage Occluder Market Estimated Size (2023) | US$ 983.5 million |
| Atrial Appendage Occluder Market CAGR (2023 to 2033) | 23.6% |
| Atrial Appendage Occluder Market Forecasted Size (2033) | US$ 8193.0 million |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global demand for atrial appendage occluders is projected to rise at a CAGR of 23.6% during the forecast period between 2023 and 2033, reaching a total of US$ 8193.0 million in 2033, according to a report from Future Market Insights (FMI). From 2018 to 2022, sales witnessed significant growth, registering a CAGR of 8.5%.
The increasing number of cardiovascular patients suffering from atrial fibrillation and thromboembolism is the primary factor contributing to market growth. Further, people's changing lifestyles, as well as the growing number of people suffering from obesity, diabetes, and hypertension, are increasing demand for the devices, contributing to market growth.
In the upcoming years, atrial appendage occluder market systems are expected to gain prominence as many new construction sites are already installing the same as a necessity. With the construction industry developing significantly in emerging regions, the demand for the Atrial appendage occluder market is expected to rise.
Certain factors, such as the limited use of the LAA occluder for patients who have a high risk of bleeding as well as stroke while on anticoagulant therapy, are limiting the market's growth. A few more factors limiting market growth include unfavorable policies and complications associated with surgery.
Growing Number of Cardiovascular Patients to Push Sales
The surging number of cardiovascular patients diagnosed with thromboembolism and atrial fibrillation worldwide is a key driver to the growth of the global atrial appendage occluder market. In addition, sedentary lifestyles and ailments like diabetes, obesity, and hypertension are also going to drive demand for such devices, paving the way for market expansion.
The global atrial appendage occluder market is extremely concentrated, with only a few players. Annually, roughly 15 million strokes occur worldwide, according to the World Health Organization (WHO). In 2010, the United States spent around US$ 53.9 billion on health care services, and drugs, and lost work days due to a heart stroke.
Ischemic strokes account for almost 87% of all strokes, which occur when blood circulation to the brain is compromised. Stroke is third among the main causes of mortality, and it is also the leading cause of long-term disability. Around 20% of ischemic strokes are caused by atrial fibrillation. All of these factors are catalyzing the growth of the atrial occluder market.
Principal Consultant
Restricted Use of LAA Occluder to Stifle the Market Growth
The restricted use of LAA occluder solely for those at high risk of stroke and bleeding while on anticoagulant medication may limit market expansion. Furthermore, difficulties associated with device implantation and removal, such as tissue erosion, which might necessitate open heart surgery, may function as a limiting factor for market expansion. Also, unfavorable policies concerning endocardial LAA closure are likely to hamper market expansion.
The Endocardial Segment is to have the Highest Demand
The endocardial segment is anticipated to have a high market share of 87.20% because they are both safe and effective. Further, several clinical studies on endocardial devices have yielded encouraging results for the patient population in terms of stroke risk reduction, contributing to the segment's market share.
The endocardial segment is likely to have a low complication rate (around 8.5%) than the Epicardial (25.4%), which is believed to drive segment growth. In addition, Epicardial has emerged as an alternative procedure for LAA closures to improve efficacy, especially in patients who have had poor results with the standard endocardial technique.
The Epicardial segment is forecasted to account for 15% of the global atrial appendage occluder market share during the forecast period.
Hospital Segment to be the Dominant Segment Acquiring 63.20% Value Share
The hospital segment of the atrial appendage occluder market is anticipated to expand notably. The growing number of hospitals and the advancement of infrastructure are expected to drive demand for the devices.
According to the Centres for Medicare and Medicaid Services, the United States spent almost 3.6 trillion US$ on healthcare management in 2018. This is expected to boost the market for atrial appendage occluder. Furthermore, the rising prevalence of atrial fibrillation is expected to play a significant role in this segment. Atrial fibrillation is one of the most common heart conditions, according to the European Society of Cardiology.
The prevalence of atrial fibrillation in people aged 65 and older was around 7.6 million in 2016, and it is expected to rise by 89%, to around 14 million by 2060. Hence, the aforementioned factors are expected to increase hospital visits for atrial appendage management, increasing demand for atrial appendage occluder in this segment.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
As per FMI, North America is anticipated to dominate the atrial appendage occluders market during the forecast period. This is because of its vast geriatric population. Moreover, the region's huge population, which accounts for the high number of stroke deaths, is the primary cause for individuals depending on atrial appendage occluders, particularly in the United States. Thus, in 2022, North America held a market share of 39.8% for atrial appendage occluder.
Europe’s Sedentary Lifestyles Favoring Market Growth
According to a report published in the journal Indian Pacing and Electrophysiology Journal, Europe’s Atrial appendage occluder market is likely to rise since more than 6 million people in Europe are already living with arrhythmia, and the number is expected to double over the next 50 years. According to one study, the European race has a great incidence of atrial fibrillation than other races.
Sedentary lifestyles and the number of persons with cardiovascular problems are predicted to rise in developed nations, driving market development in the future. This, in turn, is projected to serve the atrial appendage occluder market development. As a result of the aforementioned factors, Europe held a market share of 27.3% in the atrial occluder market in 2022.
Key players in the atrial appendage occluder market include Appriva Medical Inc., Boston Scientific, Abbott, SentreHEART Inc, and pfm Medical Ag. Occlutech, W. L. Gore & Associates, Coherex Medical, Inc., Cardia, Inc., and AtriCure, Inc. amongst others.
Key players focus on strategic formulations such as research collaborations, new product releases, market penetration, and distribution alliances for developing a commercial presence. Furthermore, these industry leaders are substantially spending on research activities, which encourage innovation and help them to commercialize improved products and maximize market income.
Recent Developments in the Atrial Appendage Occluder Market
In August 2022, Abbott and WW International, Inc. established a strategic alliance to assist people with diabetes to better understand and manage their diabetes and weight. The companies are collaborating to integrate WeightWatchers' diabetes-specific weight management program with Abbott's portfolio of FreeStyle Libre® products to create a seamless mobile experience that is going to provide people living with diabetes with information and insights.
Diabetic people can make healthy dietary adjustments, improve their glucose levels, and, ultimately, gain more control of their health through the information and insights provided.
| Attribute | Details |
|---|---|
| Growth Rate | CAGR of 23.6% from 2023 to 2033 |
| Base Year of Estimation | 2023 |
| Historical Data | 2018 to 2022 |
| Forecast Period | 2023 to 2033 |
| Quantitative Units | Revenue in US$ billion and Volume in Units and F-CAGR from 2022-2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, growth factors, Trends, and Pricing Analysis |
| Key Segments Covered | Type of Indication, Positioning of Device, End User, By Region |
| Regions Covered | North America; Latin America; Europe; East Asia; South Asia; The Middle East & Africa; Oceania |
| Key Countries Profiled | The United States, Canada, Brazil, Mexico, Germany, Italy, France, The United Kingdom, Spain, Russia, China, Japan, India, GCC Countries, Australia |
| Key Companies Profiled | Appriva Medical Inc.; Boston Scientific; Abbott; SentreHEART Inc; pfm medical ag.; Occlutech; W. L. Gore & Associates; Coherex Medical, Inc.; Cardia, Inc.; AtriCure, Inc. |
| Customization & Pricing | Available upon Request |
The global atrial appendage occluder market is estimated to be valued at US$ 983.5 million in 2023.
The atrial appendage occluder market is likely to thrive at a CAGR of 23.6% from 2023 to 2033.
The atrial appendage occluder market is projected to reach a valuation of US$ 8193.0 million by 2033.
North America is projected to lead the global atrial appendage occluder market by 2033.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type of indication
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Type of indication, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Type of indication, 2023 to 2033
5.3.1. Non-valvular Atrial Fibrillation
5.4. Y-o-Y Growth Trend Analysis By Type of indication, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Type of indication, 2023 to 2033
6. Global Analysis 2018 to 2022 and Forecast 2023 to 2033, By Procedure of positioning of the device
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Procedure of positioning of the device, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Procedure of positioning of the device, 2023 to 2033
6.3.1. Endocardial
6.3.2. Epicardial
6.4. Y-o-Y Growth Trend Analysis By Procedure of positioning of the device, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Procedure of positioning of the device, 2023 to 2033
7. Global Analysis 2018 to 2022 and Forecast 2023 to 2033, By End user
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By End user , 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End user , 2023 to 2033
7.3.1. Hospitals
7.3.2. Clinics
7.4. Y-o-Y Growth Trend Analysis By End user , 2018 to 2022
7.5. Absolute $ Opportunity Analysis By End user , 2023 to 2033
8. Global Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
8.3.1. North America
8.3.2. Latin America
8.3.3. Western Europe
8.3.4. Eastern Europe
8.3.5. South Asia and Pacific
8.3.6. East Asia
8.3.7. Middle East and Africa
8.4. Market Attractiveness Analysis By Region
9. North America Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. U.S.
9.2.1.2. Canada
9.2.2. By Type of indication
9.2.3. By Procedure of positioning of the device
9.2.4. By End user
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Type of indication
9.3.3. By Procedure of positioning of the device
9.3.4. By End user
9.4. Key Takeaways
10. Latin America Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Type of indication
10.2.3. By Procedure of positioning of the device
10.2.4. By End user
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Type of indication
10.3.3. By Procedure of positioning of the device
10.3.4. By End user
10.4. Key Takeaways
11. Western Europe Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. U.K.
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Western Europe
11.2.2. By Type of indication
11.2.3. By Procedure of positioning of the device
11.2.4. By End user
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Type of indication
11.3.3. By Procedure of positioning of the device
11.3.4. By End user
11.4. Key Takeaways
12. Eastern Europe Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. Poland
12.2.1.2. Russia
12.2.1.3. Czech Republic
12.2.1.4. Romania
12.2.1.5. Rest of Eastern Europe
12.2.2. By Type of indication
12.2.3. By Procedure of positioning of the device
12.2.4. By End user
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Type of indication
12.3.3. By Procedure of positioning of the device
12.3.4. By End user
12.4. Key Takeaways
13. South Asia and Pacific Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Bangladesh
13.2.1.3. Australia
13.2.1.4. New Zealand
13.2.1.5. Rest of South Asia and Pacific
13.2.2. By Type of indication
13.2.3. By Procedure of positioning of the device
13.2.4. By End user
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Type of indication
13.3.3. By Procedure of positioning of the device
13.3.4. By End user
13.4. Key Takeaways
14. East Asia Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. China
14.2.1.2. Japan
14.2.1.3. South Korea
14.2.2. By Type of indication
14.2.3. By Procedure of positioning of the device
14.2.4. By End user
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Type of indication
14.3.3. By Procedure of positioning of the device
14.3.4. By End user
14.4. Key Takeaways
15. Middle East and Africa Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.1.1. GCC Countries
15.2.1.2. South Africa
15.2.1.3. Israel
15.2.1.4. Rest of MEA
15.2.2. By Type of indication
15.2.3. By Procedure of positioning of the device
15.2.4. By End user
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Type of indication
15.3.3. By Procedure of positioning of the device
15.3.4. By End user
15.4. Key Takeaways
16. Key Countries Analysis
16.1. U.S.
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2022
16.1.2.1. By Type of indication
16.1.2.2. By Procedure of positioning of the device
16.1.2.3. By End user
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2022
16.2.2.1. By Type of indication
16.2.2.2. By Procedure of positioning of the device
16.2.2.3. By End user
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2022
16.3.2.1. By Type of indication
16.3.2.2. By Procedure of positioning of the device
16.3.2.3. By End user
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2022
16.4.2.1. By Type of indication
16.4.2.2. By Procedure of positioning of the device
16.4.2.3. By End user
16.5. Germany
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2022
16.5.2.1. By Type of indication
16.5.2.2. By Procedure of positioning of the device
16.5.2.3. By End user
16.6. U.K.
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2022
16.6.2.1. By Type of indication
16.6.2.2. By Procedure of positioning of the device
16.6.2.3. By End user
16.7. France
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2022
16.7.2.1. By Type of indication
16.7.2.2. By Procedure of positioning of the device
16.7.2.3. By End user
16.8. Spain
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2022
16.8.2.1. By Type of indication
16.8.2.2. By Procedure of positioning of the device
16.8.2.3. By End user
16.9. Italy
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2022
16.9.2.1. By Type of indication
16.9.2.2. By Procedure of positioning of the device
16.9.2.3. By End user
16.10. Poland
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2022
16.10.2.1. By Type of indication
16.10.2.2. By Procedure of positioning of the device
16.10.2.3. By End user
16.11. Russia
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2022
16.11.2.1. By Type of indication
16.11.2.2. By Procedure of positioning of the device
16.11.2.3. By End user
16.12. Czech Republic
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2022
16.12.2.1. By Type of indication
16.12.2.2. By Procedure of positioning of the device
16.12.2.3. By End user
16.13. Romania
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2022
16.13.2.1. By Type of indication
16.13.2.2. By Procedure of positioning of the device
16.13.2.3. By End user
16.14. India
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2022
16.14.2.1. By Type of indication
16.14.2.2. By Procedure of positioning of the device
16.14.2.3. By End user
16.15. Bangladesh
16.15.1. Pricing Analysis
16.15.2. Market Share Analysis, 2022
16.15.2.1. By Type of indication
16.15.2.2. By Procedure of positioning of the device
16.15.2.3. By End user
16.16. Australia
16.16.1. Pricing Analysis
16.16.2. Market Share Analysis, 2022
16.16.2.1. By Type of indication
16.16.2.2. By Procedure of positioning of the device
16.16.2.3. By End user
16.17. New Zealand
16.17.1. Pricing Analysis
16.17.2. Market Share Analysis, 2022
16.17.2.1. By Type of indication
16.17.2.2. By Procedure of positioning of the device
16.17.2.3. By End user
16.18. China
16.18.1. Pricing Analysis
16.18.2. Market Share Analysis, 2022
16.18.2.1. By Type of indication
16.18.2.2. By Procedure of positioning of the device
16.18.2.3. By End user
16.19. Japan
16.19.1. Pricing Analysis
16.19.2. Market Share Analysis, 2022
16.19.2.1. By Type of indication
16.19.2.2. By Procedure of positioning of the device
16.19.2.3. By End user
16.20. South Korea
16.20.1. Pricing Analysis
16.20.2. Market Share Analysis, 2022
16.20.2.1. By Type of indication
16.20.2.2. By Procedure of positioning of the device
16.20.2.3. By End user
16.21. GCC Countries
16.21.1. Pricing Analysis
16.21.2. Market Share Analysis, 2022
16.21.2.1. By Type of indication
16.21.2.2. By Procedure of positioning of the device
16.21.2.3. By End user
16.22. South Africa
16.22.1. Pricing Analysis
16.22.2. Market Share Analysis, 2022
16.22.2.1. By Type of indication
16.22.2.2. By Procedure of positioning of the device
16.22.2.3. By End user
16.23. Israel
16.23.1. Pricing Analysis
16.23.2. Market Share Analysis, 2022
16.23.2.1. By Type of indication
16.23.2.2. By Procedure of positioning of the device
16.23.2.3. By End user
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Type of indication
17.3.3. By Procedure of positioning of the device
17.3.4. By End user
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. Appriva Medical Inc.
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.2. Boston Scientific
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.3. Abbott
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.4. SentreHEART Inc
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.5. pfm medical ag.
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.6. Occlutech
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.7. W. L. Gore & Associates
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.8. Coherex Medical, Inc.
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.9. Cardia, Inc.
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
18.1.10. AtriCure, Inc.
18.1.10.1. Overview
18.1.10.2. Product Portfolio
18.1.10.3. Profitability by Market Segments
18.1.10.4. Sales Footprint
18.1.10.5. Strategy Overview
18.1.10.5.1. Marketing Strategy
19. Assumptions & Acronyms Used
20. Research Methodology
Explore Healthcare Insights
View Reports
Atrial Appendage Occluder Market
